FDA Import Refusal 112-9437436-1/1/1 — Novartis Pharmaceuticals Corporation
The FDA refused shipment 112-9437436-1/1/1 from Novartis Pharmaceuticals Corporation (United States) on March 30, 2017. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- March 30, 2017
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 66VCO99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 75